Testosterone levels at diagnosis: A key predictor of overall survival among patients with prostate cancer
Low testosterone at the time of PCa diagnosis is an independent predictor of overall survival. Findings highlight the potential of testosterone for prognostic evaluation in PCa.
Authors
- Juha P. Ahtiainen (ORCID: https://orcid.org/0000-0003-2305-4741)
- Jaakko Aaltonen (ORCID: https://orcid.org/0000-0003-2954-2674)
- Pirjo Käkelä (ORCID: https://orcid.org/0000-0002-6383-0779)
- Heikki Seikkula (ORCID: https://orcid.org/0000-0001-9942-1582)
- Eija K. Laakkonen (ORCID: https://orcid.org/0000-0001-6655-9489)
- Teemu J. Murtola (ORCID: https://orcid.org/0000-0003-2932-9590)
- Heini Huhtala (ORCID: https://orcid.org/0000-0003-1372-430X)
- Ilkka Jussila (ORCID: https://orcid.org/0009-0008-9221-3279)
- Markku Parviainen
- Heikki Pohjolainen
- Ninamaria Onni
- Koskimaa Mikko
Institutions
- Tampere University (FI)
- University of Eastern Finland (FI)
- Kuopio University Hospital (FI)
- Tampere University Hospital (FI)
- Central Finland Health Care District (FI)
- University of Jyväskylä (FI)
Publication Details
- Journal
- BJUI Compass
- Published
- 2025-02-01
- DOI
- https://doi.org/10.1002/bco2.484
- Citations
- 1
- Primary Topic
- Hormonal and reproductive studies
- Type
- article
- Field-Weighted Citation Impact
- 1.29
Funders
- Academy of Finland
- Kuopion Yliopistollinen Sairaala
- Orionin Tutkimussäätiö
- Paulon Säätiö
- Syöpäsäätiö